Literature DB >> 11120983

Affinities of beta-lactams for penicillin binding proteins of Chlamydia trachomatis and their antichlamydial activities.

C Storey1, I Chopra.   

Abstract

Binding affinities of beta-lactam antibiotics for the three penicillin binding proteins (PBPs) from Chlamydia trachomatis were determined in vitro and compared with their antichlamydial activities. Mecillinam selectively inhibited PBP1, with a 50% inhibitory concentration for PBP1 binding (0.2 microg/ml) similar to the MIC (0.1 microg/ml) and minimum bactericidal concentration (0.25 microg/ml). Although the other beta-lactams inhibited a wider range of PBPs than mecillinam, their antichlamydial activities were inferior to that of mecillinam.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120983      PMCID: PMC90278          DOI: 10.1128/AAC.45.1.303-305.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

Review 1.  Lack of cell wall peptidoglycan versus penicillin sensitivity: new insights into the chlamydial anomaly.

Authors:  J M Ghuysen; C Goffin
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  In vitro drug susceptibility of Chlamydia sp. strain TWAR.

Authors:  C C Kuo; J T Grayston
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

Review 3.  Treatment of Chlamydia trachomatis genital infection.

Authors:  K E Toomey; R C Barnes
Journal:  Rev Infect Dis       Date:  1990 Jul-Aug

4.  Competition of beta-lactam antibiotics for the penicillin-binding proteins of Pseudomonas aeruginosa, Enterobacter cloacae, Klebsiella aerogenes, Proteus rettgeri, and Escherichia coli: comparison with antibacterial activity and effects upon bacterial morphology.

Authors:  N A Curtis; D Orr; G W Ross; M G Boulton
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

5.  A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain.

Authors:  S J How; D Hobson; C A Hart; E Quayle
Journal:  J Antimicrob Chemother       Date:  1985-04       Impact factor: 5.790

6.  In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  D H Martin; J G Pastorek; S Faro
Journal:  Sex Transm Dis       Date:  1986 Apr-Jun       Impact factor: 2.830

7.  Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid.

Authors:  A G Barbour; K Amano; T Hackstadt; L Perry; H D Caldwell
Journal:  J Bacteriol       Date:  1982-07       Impact factor: 3.490

8.  In vitro activity of a group of broad-spectrum cephalosporins and other beta-lactam antibiotics against Chlamydia trachomatis.

Authors:  M R Hammerschlag; A Gleyzer
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

9.  Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity.

Authors:  N A Curtis; D Orr; G W Ross; M G Boulton
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

10.  Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci.

Authors:  A Matsumoto; G P Manire
Journal:  J Bacteriol       Date:  1970-01       Impact factor: 3.490

View more
  8 in total

Review 1.  Biochemistry and comparative genomics of SxxK superfamily acyltransferases offer a clue to the mycobacterial paradox: presence of penicillin-susceptible target proteins versus lack of efficiency of penicillin as therapeutic agent.

Authors:  Colette Goffin; Jean-Marie Ghuysen
Journal:  Microbiol Mol Biol Rev       Date:  2002-12       Impact factor: 11.056

2.  Differential requirement for PBP1a and PBP1b in in vivo and in vitro fitness of Vibrio cholerae.

Authors:  Tobias Dörr; Andrea Möll; Michael C Chao; Felipe Cava; Hubert Lam; Brigid M Davis; Matthew K Waldor
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

3.  Functional and biochemical analysis of Chlamydia trachomatis MurC, an enzyme displaying UDP-N-acetylmuramate:amino acid ligase activity.

Authors:  Lars Hesse; Julieanne Bostock; Sebastien Dementin; Didier Blanot; Dominique Mengin-Lecreulx; Ian Chopra
Journal:  J Bacteriol       Date:  2003-11       Impact factor: 3.490

4.  In vitro and in vivo functional activity of Chlamydia MurA, a UDP-N-acetylglucosamine enolpyruvyl transferase involved in peptidoglycan synthesis and fosfomycin resistance.

Authors:  Andrea J McCoy; Robin C Sandlin; Anthony T Maurelli
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

5.  Commonly prescribed β-lactam antibiotics induce C. trachomatis persistence/stress in culture at physiologically relevant concentrations.

Authors:  Jennifer Kintner; Dawn Lajoie; Jennifer Hall; Judy Whittimore; Robert V Schoborg
Journal:  Front Cell Infect Microbiol       Date:  2014-04-11       Impact factor: 5.293

6.  Penicillin induced persistence in Chlamydia trachomatis: high quality time lapse video analysis of the developmental cycle.

Authors:  Rachel J Skilton; Lesley T Cutcliffen; David Barlow; Yibing Wang; Omar Salim; Paul R Lambden; Ian N Clarke
Journal:  PLoS One       Date:  2009-11-06       Impact factor: 3.240

7.  Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice.

Authors:  Maud Dumoux; Sylvain M Le Gall; Mohamed Habbeddine; Christiane Delarbre; Richard D Hayward; Colette Kanellopoulos-Langevin; Philippe Verbeke
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 8.  Chlamydial Antibiotic Resistance and Treatment Failure in Veterinary and Human Medicine.

Authors:  Nicole Borel; Cory Leonard; Jessica Slade; Robert V Schoborg
Journal:  Curr Clin Microbiol Rep       Date:  2016-02-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.